Thank you, readers! That's all from CNBCTV18.com's live market coverage on July 29, 2022. Stay tuned for other updates on our website: CNBCTV18.com.

You can follow us on Twitter: @CNBCTV18Live @CNBCTV18News

And on Facebook, LinkedIn, Instagram and Telegram

Download our mobile app for Android and iOS platforms

Jul 29, 2022 5:10 PM

Expect a correction soon after 17,300-17,400 levels: Ambareesh Baliga

Independent market expert Ambareesh Baliga tells CNBC-TV18 that in his view, investors should have their strategies right. "If your view has gone wrong, the strategy comes into play, and Plan B... I basically book out to a certain extent, whatever I bought in the last two months, because those levels were extremely great... I still don't expect the new bull run to start from here because there is still a lot of pain in the global economy," says Baliga, who had not expected the Nifty50 to go much beyond 16,400-16,500 levels.

"Even the second quarter earnings may not really excite the market very much. It's only from the third quarter that we should see sort of a decent uptick. I'm clearly expecting a correction sooner or later; we could see possibly something 17,300-17,400 but then after that, we should again see a correction. I would be booking out to a certain extent," he adds.

Jul 29, 2022 4:28 PM

Market At Close | Sensex and Nifty50 at fresh 3-month closing highs

Jul 29, 2022 3:55 PM

Rupee appreciates by 51 paise vs US dollar — its best single-day gain in a year

Jul 29, 2022 3:44 PM

Jul 29, 2022 3:03 PM

Jul 29, 2022 2:45 PM

Shares of HDFC trading 0.8% up

Jul 29, 2022 2:26 PM

Positive on Divi’s Laboratories: Jigar Mistry

Jigar Mistry, Co-Founder, Buoyant Capital said, "The one that we have been positive on is Divi’s Laboratories. I think the Street was extremely pessimistic on the molnupiravir, which people believed was one of molecules and that would drive away the increase in profitability that Divi’s Laboratories was consistently reporting." Mistry added that Divi’s Laboratories never speaks about their players and the companies that they're working with. "So that's one business that we have liked and among the only one that we have in the portfolio right now"

Jul 29, 2022 2:04 PM

Sun Pharma jumps 5.7% post earnings announcement

Jul 29, 2022 1:57 PM

Ashok Leyland 1.75% down after reporting below expectations Q1 earnings

Jul 29, 2022 1:43 PM

LT Foods near day's high

Jul 29, 2022 1:21 PM

Deepak Fertilisers and Petrochemicals at day's high

Jul 29, 2022 1:12 PM

Jul 29, 2022 12:46 PM

Buy Reliance Industries, Infosys, Tata Motors: Rahul Mohindar

Here are three recommendations by Rahul Mohindar of viratechindia.com:

-- Buy Reliance Industries Ltd for a target of Rs 2,570 with a stop loss of Rs 2,460

-- Buy Infosys for a target of Rs 1,650-1,730 with a stop loss of Rs 1,485

-- Buy Tata Motors for a target of Rs 460-470 with a stop loss of Rs 440

Jul 29, 2022 12:19 PM

Jul 29, 2022 11:41 AM

Load more